Investor Relations Corporate Profile Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. RECENT NEWS May 15, 2019 Evolus Announces First Shipment of Jeuveau™ (prabotulinumtoxinA-xvfs) to Customers in the United States April 30, 2019 Evolus Reports First Quarter 2019 Financial Results April 29, 2019 Evolus to Participate in Two Upcoming Investor Conferences View all EVENTS Bank of America Merrill Lynch Healthcare Conference 2019 May 14, 2019 at 3:40 PM PDT Evolus Investor & Analyst Day May 8, 2019 at 9:00 AM EDT SunTrust 5th Annual Life Sciences Summit May 7, 2019 View all PRESENTATIONS May 2019 Evolus Investor and Analyst Day Presentation May 08, 2019 May 2019 Investor Presentation Apr 30, 2019 Aesthetic Surgery Journal Apr 08, 2019
May 15, 2019 Evolus Announces First Shipment of Jeuveau™ (prabotulinumtoxinA-xvfs) to Customers in the United States